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ABSTRACT

Proteoliposome Proton Flux Assays Establish Net Conductance, pHSensitivity, and Functional Integrity of a Novel Truncate
of the M2 Ion ―Channel‖ of Influenza A

Emily Peterson
Department of Physiology and Developmental Biology
Master of Science

A novel truncate of Influenza A M2 protein (residues 22-62), incorporated into a
uniquely tailored proteoliposome proton uptake assay, demonstrated proton flux more
characteristic of an ion transporter than a traditional ion ―channel.‖ The liposome paradigm was
essential for testing the conductance activity of this M2 truncate at a range of extraphysiological
pHs appropriate for channel vs. transport function determination. In addition to transportertypical proton flux, M2(22-62) showed the key characteristics of functional integrity: selective
proton uptake into liposomes and block of uptake by amantadine. Two sets of proteoliposome
proton flux assays were carried out, Set 1 at pH values of 6.5, 6.0. 5.5, 5.0, and 4.5; Set 2 at pH
values of 6.25, 6.0, 5.75, 5.5, 5.25, 5.0, and 4.75. Observed flux rates followed a proton
transport saturation curve similar to that observed in mouse erythroleukemia cells 1. Proton
transport was maximal at pH 5.5 in Set 1 (139 H+/second/tetramer) and at pH 5.75 in Set 2 (43
H+/second/tetramer). Amantadine block was strongest at pH 5.5 in Set 1 and 6.25 in Set 2, and
apparent desensitization of the protein severely reduced proton flux and amantadine sensitivity
below pH 5.5 in both sets of experiments. Decreased external pH increased proton uptake with
an apparent pKa of 6 (Set 1) or 6.5 (Set 2). These data indicate acid activation of M2(22-62)
between pH 5.5-6, optimal amantadine block between pH 5.5-6.25, and a loss of peptide
functionality between pH 5.9-4.7.

Keywords: Influenza A, M2 protein, proton transporter, proton channel, acid activation,
proteoliposome, liposome, amantadine
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Proteoliposome Proton Flux Assays Establish Net Conductance, pH-Sensitivity, and Functional
Integrity of a Novel Truncate of the M2 Ion ―Channel‖ of Influenza A

INTRODUCTION
Justification for Research
Influenza A M2 is a 97-residue, homotetrameric integral membrane protein that forms a
H+-selective pore in cell compartment membranes. The initial function of this proton
conductance is to lower the pH inside the viral capsid, dissociating the genome and
ribonucleoproteins from each other. Later, when nascent virions are assembled and awaiting
release in membranous ―envelopes‖ from the cell, M2 regulates the pH inside trans-Golgi
vesicles to stabilize viral envelope proteins such as pH-sensitive hemagglutinin2.
The M2 protein is the target of the anti-influenza adamantane-derived drugs amantadine
and rimantadine. Amantadine has been in wide use since the 1970s3, and in the last few years
(since about 2002) almost all emerging strains of influenza—including the most recent pandemic
H1N1 strain4--have been shown to contain mutations in the M2 gene that confer viral resistance
to these drugs.
This recent development in the fight against a very threatening human disease--as well as
a desire to enhance knowledge and understanding of ion channel structure and function—has led
myself and fellow investigators to consider the M2 protein a critically important subject of
research. Some of the most key structural and functional characteristics of this protein are still
unsettled in the field. For example, what is the exact rate of proton movement through the
protein? Estimates have varied from 20/second in proteoliposome studies 5 to 3000/second in
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Xenopus oocytes6. How does amantadine block M2, and why are various mutants resistant to
the drug? This question must rely heavily on structural studies such as x-ray crystallography and
NMR, but functional assays are critical in verifying the integrity of protein mutants, truncates,
and synthesized peptides thus tested. And finally, what is the mechanism of proton flux? Is M2
a traditional transmembrane ―channel,‖ with ion passage limited only by concentration and
electrical gradients across the membrane? Or is it more of a ―transporter,‖ with a maximum rate
of H+ transport limited by integral structural features of the protein, no matter how strong the
driving forces on either side of the membrane7,8?
In order to study M2-mediated ion flux across membranes, researchers have used a small
variety of both in vitro and in vivo electrophysiological techniques: protein-induced flux
measured by electrical current flow across a planar bilayer8; two-electrode voltage clamping of
M2-expressing mouse erythroleukemia cells, CK-1 cells, or Xenopus laevis oocytes1,2,5,6; or
measurement of pH change inside or outside an M2 proteoliposome suspension3,4,7.
Four distinctive characteristics of M2 activity have been well established in oocytes6,9-12
and mammalian cells1,13,14: proton selectivity6,10,12, acid activation11, amantadine sensitivity15,
and basic block of proton backflux8,11. These characteristics are used as markers of protein
function and integrity in M2 studies done now in any in vivo or in vitro system. Proton flux data
from voltage-clamped MEL cells have also shown that H+ conductance through M2 reaches
saturation at pH 4.0, with an apparent pK of 6.01. One of the primary aims of this thesis
research was to provide additional conductance studies (in liposomes) to help determine whether
this fifth property, structurally-determined maximal (―saturated‖) H+ flux with a pK of 6, can be
included in the list of characteristic M2 behaviors.
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Cultured cell or oocyte experiments are useful for providing an in vivo study method that
eliminates uncertainties about correct protein synthesis, processing, and folding, as well as
questions regarding membrane composition and proper protein insertion/orientation within the
membrane. However, an entire oocyte plasmalemma can contain M2 tetramers by the billion,
and even patch clamping a relatively small section of the membrane still yields a section with
huge numbers of ion channels—and not all of the membrane proteins will be M2. Furthermore,
quantitation of tetramers within the plasmalemma is restricted mainly to imprecise
immunoblotting methods, leaving the per-channel flux calculations dependent on possible overor underestimates of active M2 protein in the membrane.
Planar bilayers provide a method for precisely controlling solution/ion composition on
either side of the membrane, membrane lipid species ratios, bilayer thickness, and density of
inserted protein (from an expression system such as transfected E.coli or SF9 cells). However,
problems arise from the surface strain due to suspension, and possibly from the planar shape of
these artifical bilayers. Previous planar bilayer studies with M2 yielded high conductance and no
amantadine block, seeming to indicate unusual protein configurations or aggregation, possibly as
a consequence of the lateral pull exerted by the abnormal tautness and flatness of the bilayer16.
The most natural in vitro system in which to study M2 function is the proteoliposome2,4,7.
This method combines the precise control over protein-lipid ratio, lipid composition, and bath
solution components gained by a planar bilayer assay, with the advantages of unstrained,
spontaneously-formed lipid-protein spheres similar in size to an actual Influenza virus17. The
liposome assay is more effective than Xenopus oocyte assays when using truncated M2 peptides,
yet provides equally robust data18,19. Liposomes can also withstand a much broader pH range
than what is physiologically tolerable for cell or tissue culture models. For these reasons,
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proteoliposome assays were chosen as the experimental paradigm in this effort to determine
maximum single-channel flux rates through M2.

Figure 1.
Whole-cell voltage clamp of M2-transformed mouse erythroleukemia cells, from Chizhmakov,
et. al1. Legend in original publication: ―Effect of pHo on M2 conductance. A, chord conductance
g=IH/(V-EH) normalized to pHo 4 at -60 mV plotted against pHo at -60 and +60 mV; pHi 7.4.
Single site binding function was fitted by least-squares regression with a Kp of 1.2 µM at -60 mV
and 2.3 µM at +60 mV.‖

Investigators using whole-cell clamp measurement of M2-induced proton flux into mouse
erythroleukemia cells obtained the single-site binding curve in Figure 1, suggesting transporterlike H+ flux function in M2, rather than channel-like proton passage. But no researchers have yet
examined this suggestion by testing M2-induced proton flux in liposomes using a stepwise array
of pH values. This approach can be optimally used with the liposome system, rather than live
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cells, and is capable of determining whether M2 functions on a more subtly pH-dependent proton
passage continuum, rather than simply being ―active‖ or ―inactive.‖

Figure 2.
A) Resistance across a membrane and through a protein pore. B) Steps of ion transport through a
membrane protein pore. Redrawn from Hille, B. Ion Channels Of Excitable Membranes, p. 352
and 369.
Figure 2 illustrates the mechanics of proton movement through a membrane-inserted
protein pore. Movement of ions (left to right) to the mouth of the pore constitutes the access
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resistance, which corresponds to a ―proton depletion zone‖ at the N-terminus of the M2 protein.
Diffusion or translocation through the pore is the second step, the speed of which is used to
distinguish between channel or transporter protein function. And at the far end—the right side of
both figures, the C-terminus of M2 and interior of the proteoliposomes—the movement of ions
away from the channel also contributes to the rate at which subsequent ions can move through
the protein8,20.
While proton channels such as gramicidin A or the artificially-synthesized ―LS2‖ channel
may not exhibit significantly higher proton conductance levels than transporters at low [H+]
levels21,22, they can be distinguished by ―saturation‖ of proton flux at high [H+]8. If inherent
structural limitations of a protein prevent ion passage through the pore from increasing in direct
relation to ion concentrations on either side of the pore, the flux through the protein will plateau,
or ―saturate‖ at the point where ion movement becomes protein-limited. This characteristic
becomes a major distinguishing feature between proton/ion ―channels‖ and ―transporters.‖
To investigate whether flux saturation was occurring with M2 in a liposome environment,
this thesis project was designed to conclusively determine the basic characteristics of H+
movement through the conductance domain of M2 (residues 22-62), elucidating:
1. H+ flux into proteoliposomes at various pHs to distinguish between channel-type or
transporter-type proton conductance;
2. Acid-activated conductance patterns, including determination of optimal pH;
3. Impact of concentration gradients, both of H+ and other cations essential to the assay,
on flux rate and liposome proton uptake capacity;
4. Amantadine efficacy in blocking H+ flux at various pHs;
5. Functional integrity (determined via the above parameters) of the M2(22-62) truncate.

6

Using a novel M2 truncate of residues 22-62 (the transmembrane alpha-helix, plus a
short, amphipathic ―anchor‖ on the C-terminal end) developed by collaborators at Florida State
University16, the research presented here validated the hypothesis that M2 functions as a proton
transporter, rather than a traditional, proton-selective ―channel‖.
A portion of the results presented here have been reported previously20,23.

EXPERIMENTAL DESIGN
Liposome Assay Introduction
The liposome assay, as mentioned above, allows experimentation at pHs outside of the
range of physiological tolerance. Because M2 is a proton transporter, manipulation of extra- and
intraliposomal pH is crucial to determining whether the protein is allowing H+ flux to occur in
response to increased [H+], necessitating sometimes very acidic experimental pH. Another
reason the liposome assay is so valuable is that, depending on liposome diameter, an artificial
―cell‖ is created. The lipid bilayer surrounding this tiny sphere is composed of a natural cellular
(E. coli) lipid extract, and when suspended in an aqueous solution, the lipids are associated with
much the same tensile strength, bilayer thickness, and lipid fluidity that would be found in a
natural cell. However, rather than having multiple other membrane proteins, cytosolic proteins,
endo- and exocytotic activity, continual cell metabolism activity, etc. taking place constantly in
order to maintain the membranous sphere, the lipids are thermodynamically stable all by
themselves. The liposome can hold whatever buffer or salt solution the experimenter desires (as
long as the osmolarity across the liposome membrane is balanced.)
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Cell membranes act as capacitors in vivo, separating electrical charges associated with
various ions and building up potential electrical energy across the membrane. Liposomal
membranes are just as effective at this energy buildup, and in our proton flux assay we take
advantage of that by building up a strong electrical gradient across the membrane. Once the
liposomes are diluted into an osmotically balanced but K+ and H+-asymmetrical solution, they
contain a (relatively) high concentration of K+ cations from KCl and potassium phosphate buffer.
The overall charge inside the liposomes is balanced. But the K+-motive force is outwards, due to
the very low (almost negligible) extraliposomal [K+].
Initially, without any means of transport across the membrane, K+ is unable to follow its
concentration gradient out of the liposomes. At this point in the experiment, M2 is present in the
liposomal membrane (though only half of the M2 tetramers would be expected to be oriented
correctly to pass protons into the spheres.) As soon as the liposomes are added to a solution of
M2-active pH (<7) they’re ready to begin allowing protons to follow their concentration gradient
(from 75-fold to 10,000-fold, depending on extra-liposomal pH) and move into the liposomes.
But as soon as one or two positively-charged protons pass that membrane barrier without
bringing an anion with them, the charge inside the liposomes has built up to become so positive
that the electrical repulsive force on H+ equals the chemical gradient force, and Nernst
equilibrium is reached. No protons can move until the potassium ionophore valinomycin is
added to the experiment, which allows K+ to leave the liposomes much more quickly than H+ can
enter them (meaning proton flux is not limited by any factor other than M2 structure). This
actually produces a membrane potential, Vm that drives H+ into the liposomes.
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Figure 3.
Graphical representation of a typical proton-flux liposome assay. Large circle represents a single
liposome, with internal solution elements listed. Proteins &/or ionophores (valinomycin,
carbonyl cyanide 3-chlorophenylhydrazone) that can permeate the lipid membrane are shown,
with the ions they transport and the direction of ion flux. The pH/time trace has arrows
indicating addition of either liposome (―vesicle‖) suspension or ionphore solution to the
experiment.

The paradigm used consisted of two major elements: 1) composition/preparation of
liposomes, and 2) the actual proton flux assay. Both the liposome preparation and liposome
assay techniques were improved in small ways during the ~8 months between Set 1 (Oct. 2009,
Jan-Feb. 2010) and Set 2 (July-Oct. 2010) of ―activation-saturation‖ proton flux assays reported
here. Changes were primarily in lipid/peptide drying and solublization methods, and amantadine
treatment, and are noted.
9

Proteoliposome composition/preparation
The M2(22-62) truncate used in these liposome assays included the transmembrane
domain and post-transmembrane amphipathic helix20. The construct, expressed in transfected E.
coli BL21 (DE3), was comprised of an N-terminal 6-histidine tag followed by the large, soluble
maltose binding protein, then a Tobacco Etch Virus-protease cleavage site, and finally the
insoluble M2(22-62) peptide. The fusion protein was collected from the bacterial membrane
fraction by solubilization with dodecylmaltoside, and purified via affinity chromatography with a
nickel-nitriloacetic acid-treated agarose bead column. The peptide was cleaved from the fusion
protein with TEV protease for 20 hours. The reaction mixture was precipitated with
trichloroacetic acid and lyophilized. The cleaved M2(22-62) amino acid sequence was:

SNASSDPLVVAASIIGILHLILWILDRLFFKSIYRFFEHGLKRG
The peptide was solubilized using methanol and the concentration determined by absorbance at
280 nm using a generic extinction coefficient (1 ml mg-1 cm-1). It contained a fragment of the
TEV cleavage site (Ser, Asn, Ala) at the N-terminus, such that the total length was 44 amino
acids, with a calculated molecular weight of 5014.9 Da. Methanol-solublized peptide was
received in July 2009, aliquoted into 1.5 mL portions, and stored long-term at -80 C or shortterm at -20 C until use in October 2009, January-February 2010, and August-October 2010.
Desired size of a liposome ―batch‖ was determined, and a corresponding amount of E.
coli polar lipid extract (Avanti Polar Lipids) in chloroform was measured into an organicsolvent-washed and N2-dried glass bulb or culture tube. Using the known protein concentrations
of M2 protein truncate now suspended in a 50% methanol/50% chloroform solvent, protein was
added to the still-suspended lipid (Set 1 of activation-saturation experiments, Figure 7), or, with
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extra methanol, to a vacuum-dried thin lipid film (second set of activation-saturation
experiments, Figure 8). If preparing ―blank‖ (protein-free) control liposomes, only pure methanol
was added. It was experimentally determined that the optimal protein-lipid ratio for these assays
is 1:200 (Fig. 17, Appendix), which was adopted as the standard liposome composition ratio for
these experiments. The still-suspended protein and lipid were then vortexed thoroughly, dried
under N2 to a thin film on the glass, then further dried under a vacuum for 1-2 hours (Set 1) or
not (Set 2).
The extrusion filter apparatus was assembled and warmed in a 50-55 C incubator.
Liposome internal buffer (description follows in ―Proton flux assay design and execution‖
section) was also warmed to the same temperature. The mixture was heat-extruded: 1) to ensure
that the sample was above the liquid-gel phase transition temperature of the lipid, allowing
complete formation of lipid into properly sized liposomes, and 2) to facilitate ease of extrusion,
as room-temperature extrusion frequently required enough force on the syringe plungers to
rupture the thin polycarbonate filter membrane. The lipid-protein thin film was also warmed in
the incubator to 50-55 C.
Warmed internal buffer was then added to the lipid/protein film, and the solution
vortexed thoroughly (occasionally requiring up to 30 seconds of bath sonication to remove lipid
from the glass walls), until visual confirmation established that all lipid and protein was
suspended in the solution. The liposome suspension would appear quite milky at this point, due
to the varied light diffraction by spontaneously-formed liposomes. This milky appearance was
taken to indicate a predominance of liposomes of diameter larger than the wavelength of visible
light, or >800 nm. The suspension was then passed 21 times (standard protocol for liposome
extrusion) through an extrusion filter apparatus consisting of two glass gastight syringes affixed
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to metal probes inserted into Teflon blocks, which are fitted into a metal housing that firmly
sealed a porous polycarbonate filter membrane between the blocks. Either of two different units
were used: Avestin LiposoFast Basic, Avestin, Inc., Ottawa, Canada and Avanti Mini-Extruder,
Avanti Polar Lipids, Alabaster, AL, USA. Filter membranes of 100 nm diameter pore size were
used, which yielded liposomes of uniform diameter from 120-150 nm, the majority being close
to 130 nm, as determined by Dynamic Light Scattering (see below). Successful extrusion was
also visually confirmed—as a qualitative, subjective determinant—by the observation that the
extruded liposome suspension became much less opaque after extrusion.
Liposomes were used within 1-7 (Set 1) or 1-14 (Set 2) days of preparation, to avoid
settling and aggregation of liposomes or possible protein deterioration. For amantadine
sensitivity determination, a portion of the extruded liposome suspension was separated, and
amantadine added to a concentration of 0.1 mM (Set 1) or 0.2 mM (Set 2). All samples were
stored at 4 C.
All liposome batches were analyzed with Dynamic Light Scattering (―90Plus‖ instrument
model, Brookhaven Instruments, Holtsville, NY, USA) for size uniformity. Test batches of
liposomes were assayed for lipid & protein content after extrusion, to verify protein:lipid ratios
and final concentrations in a typical batch. An assay for phosphate quantitation24 indicated no
significant difference in lipid present before extrusion or after extrusion with either brand of
extruder (see Appendix). Protein assay efforts here were unsuccessful (see Appendix), but during
my attempts a group of researchers shared results using a modified detergent-compatible
commercial (BioRad DC Protein Assay) colorimetric protein assay to quantitate protein amounts
in liposomes after extrusion, detergent-mediated lipid solublization, and Bio-Bead treatment25.
Their data indicated that more than 95% of purified full-length M2 protein successfully
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incorporated into mixed-phospholipid liposomes at pH 6.2 and above. Their method would have
more avenues for protein loss than the method described here, and therefore this relatively
simple extrusion method is assumed to be similarly protein-retentive.

Proton flux assay design and execution
The proton flux assay used here was based on the Franklin/Moffat/Woodbury proton
uptake assay26. As mentioned above, the assay utilized a high concentration of K+ cations inside,
relative to outside, the liposomes, which could efflux upon introduction of the K+ ionophore
valinomycin, carrying positive charge out to allow proton influx through M2. A second major
characteristic of the intraliposomal solution was a relatively high buffer concentration, keeping
the entrant protons bound and out of the way for new proton entry, essentially indefinitely, at the
buffer concentrations used here. Flux measurements were taken from the initial 10 seconds of
proton influx, when the intraliposomal buffer was far from Nernst equilibrium. Solution
compositions were: internal liposome buffer: 50 mM KCl, 100 mM K+ phosphate (half as
K2HPO4, half as KH2PO4), 320 mOsm, pH 8; external liposome buffer: 165 mM NaCl, 2 mM
citrate (1.67 mM Na+ citrate, 0.33 mM citric acid), 330-340 mOsm. The external buffer solution
was titrated appropriately (with HCl or NaOH) to bring experimental pH to 6.5, 6.25, 6.0, 5.75,
5.5, 5.25, 5.0, 4.75, 4.5, or 4.0 after addition of 1% volume of liposomes in internal buffer. For
example, for experimental conditions of pH 6.5, the external buffer pH alone had been titrated
beforehand to 6.0, and addition of liposomes at pH 8 brought the experimental pH up to 6.5. For
a pH 4.0 experiment, external buffer of 3.5 initial pH was used; and so forth for all other pH
values. Osmolarity of external buffer, even after re-titration to a few different pH values, did not
exceed 340 mOsm.
13

The external liposome buffer was osmotically balanced with the internal by using NaCl,
which supplied anions impermeant to the liposomes. Protein-free, ―blank‖ liposome control
preparations were also tested, showing less permeability to K+ and greater resistance to
depolarization. When testing liposomes incubated in 0.1-0.2 mM amantadine, amantadine
solution (30 µL of 10 mM) was added to the 3 mL external buffer ―bath‖ to maintain amantadine
concentration at 0.1 mM once the liposome aliquot was diluted into that buffer.
At initiation of the assay, the pH microelectrode was placed in the 3 (or 3.03, if
amantadine was added) mL bath of external buffer. pH changes were recorded as voltage
changes, measured with a pH meter having its output connected to a -100-gain amplifier with
variable offset such that voltage equaled offset plus 5.7 volts per pH unit. The voltage changes
were tracked with an analog-to-digital converter installed in a computer using the LabView data
acquisition program, and the experimenter also noted the reading from the pH meter at crucial
points during the experiment (for comparison and to register the DC offset employed). After
tracking any slight pH changes or equipment-induced voltage change (―drift‖) for 1-2 minutes,
an aliquot of 30 µL of liposomes was injected into the rapidly stirring solution. Since the
liposomes were suspended in internal buffer and only trapped ~5% of the volume, they added a
nearly 100-fold dilution of internal buffer to the composition of the now-3.03 (or 3.06) mL
external buffer volume. (The resulting pH change was accounted for in the composition of the
external buffer, as noted above.) Amantadine was measured to have a negligible effect on pH
when added to the bath.
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Figure 4.
Raw pH/voltage change data plotted over time for two proteoliposome proton flux assays at pH
6.5 (from experiment Set 1). Liposomes were comprised of 0.1 mg M2(22-62): 20 mg E.coli
lipid extract: 1 mL internal buffer. Upper left corner legend identifies proteoliposomes only (blue
trace) and proteoliposomes incubated and assayed in 0.1 mM amantadine (red trace). Key time
points in the experiment are indicated with arrows: valinomycin injection (black), CCCP
injection (green), two back-titrations of 30 nEq each of HCl (purple). Traces were vertically
offset for comparison purposes.
After allowing 1-2 minutes for full equilibration of the bath and to track any drift seen in
the presence of the liposomes, 4 µL valinomycin (in ethanol) was injected into the bath. This
amount was calculated based on the lipid amount used and size of the liposomes. With 10 mg of
lipid at about 750 g/Mol, factoring in that each molecule had an average headgroup size of 0.64
nm2, the total lipid surface area would be 6.4 x 1017 nm2. With 100 nm-diameter liposomes, that
translated to 2 x 1013 liposomes in a 0.5 mL liposome preparation. In 30 µL (one experiment),
15

then, there would be 1.22 x 1012 liposomes. These experiments employed 4 µL of 25 µg/mL
valinomycin (in ethanol), with a formula weight of 1111.36 g/Mol. That amount would yield 5.3
x 1013 molecules of valinomycin per experiment, meaning that there were about 43 valinomycin
molecules per liposome, more than enough to keep K+ transport from being rate-limiting.
Depending on which liposomes were being tested, the pH (and hence, voltage recorded
by the amplifier) would rise precipitously or only slightly, but always ―leveled off‖ within about
one minute of valinomycin addition. An additional minute was allowed to pass, then 25 µL of
200 mM CCCP (also in ethanol), a protonophore, was injected into the bath. This proton
transporter maximized the proton influx capability of the liposomes, giving a measurement that
reflected the total proton-uptake capacity of all liposomes in the experiment. The CCCP volume
used was, as with valinomycin, based on the calculated number of liposomes in the experiment.
25 µl of 200 uM CCCP, added to the 1.22 x 1012 liposomes in the experiment, provided 3 x 1015
CCCP molecules per experiment, or 3000 CCCP molecules for every liposome.
A pH/voltage maximum was reached very quickly (within 10 seconds) after CCCP
addition. After a two-minute recording of this very stable pH plateau, 30 nanoMoles of H+ (as
HCl) were injected into the vial (30 µL of 1 mM HCl), referred to as a ―back-titration.‖ As the
liposomes were then fully permeable to protons, the buffer inside them had effectively become
part of the overall bath. When a measured number of protons in the form of HCl were then
added, then ensuing pH/voltage change could be used use as a gauge to calibrate proton influx
into the liposomes. The addition of 30 nanoMoles of HCl was repeated a second time, post-hoc
additions of valinomycin and CCCP were made to test their direct effects on pH, and the
experiment was concluded.
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Data extraction
Using Microsoft Excel, data points were hand-selected (see Fig. 5) from the data trace to
calculate proton flux at various key time points during an experiment. First, the two backtitration voltage differences were calculated and averaged to give the pH electrode voltage (in
mV) for exactly 30 nanoMoles of H+ flux. This could vary with buffer titration, so it was
important that pH change be restricted to a narrow range, within a few hundredths of a pH unit
from the other measurements in the experiment.
Next, a 10-second set of data points was taken, beginning just after the valinomycin peak
and ending 10s into the peak, to calculate the initial slope of voltage change upon addition of the
potassium ionophore. The following formula was used to fit the data progression from steep
curve to gentler rise during these 10 seconds:

m

N

xi yi

xi yi

N

xi2

xi

2

(1)

This enabled calculation of the initial proton-influx slope, or ―initial slope,‖ which was decided
upon as being the most important quantitative measurement of M2 H+ conductance.
The slope of the trace immediately before valinomycin addition was also calculated, to
provide a measurement of the small, usually upward/basic pH drift from slow depolarization of
the liposomes due to leak conductance of K+. This pre-valinomycin drift was subtracted to
correct the raw valinomycin initial slope. To correct for artifactual voltage changes induced by
injection of the ethanol-suspended ionophores, post-hoc valinomycin and CCCP injections were
also carried out for the experiments in Set 2.
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Figure 5.
Liposome assay from Set 2 showing typical analysis protocol. Experimental pHo 6.0, liposome
suspension of 0.1 mg M2(22-62): 20 mg E.coli lipid extract: 1 mL internal buffer, pHi 8.0.
Voltage change (y axis) plotted against time in seconds (x axis) in Microsoft Excel for analysis.
Green cursor ( 145s) was placed at valinomycin peak, with red bar to the left showing data
points being averaged to obtain pre-valinomycin ―drift‖ slope, and red bar to the right showing
data points averaged (via Equation 1) from 2s post-valinomycin to obtain initial slope. The faint
purple and bright pink cursors were placed at the beginning of both HCl back-titrations to
calculate the voltage change from pre-cursor to post-cursor, yielding two values for the voltage
change induced by 30 nEq of H+. Dotted red lines aided in accurate placement of back-titration
cursors.
The calculated valinomycin-induced voltage change was then related to H+ flux, or pH.
Dividing the valinomycin slope by the average ∆V for 2 back-titrations of 30 nmoles HCl each
yielded a H+ flux value in units of 30 nM H+/sec, which was converted to units of H+/second.
However, this value was comprehensive for the proton flux from all M2 tetramers in all
liposomes in the experiment. Dividing by the number of nanoMoles of tetramers of M2 in that
sample gave a per-tetramer value for M2 conductance.
One final correction was necessary: because the liposomes were artificially mixed and
assembled, we followed the example of previous liposome investigations and assumed that half
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of the tetramers present were oriented C-terminus-out27, which is a primarily non-conducting
state (though voltage clamping of MEL cells did indicate some C-to-N proton backflux when
concentration and electrical gradients were oriented favorably14). The newly-described
detergent-to-lipid BioBead-mediated solublization of extruded liposomes was shown via mass
spectrometry in a recent study to produce liposomes with all M2 protein oriented N-terminusout25, but our methods were different enough to render an assumption of similar orientation
inapplicable to the data presented here. It was assumed that the basic pH inside the vesicles
would block proton uptake by the 50% of tetramers whose N-termini were inside the liposomes,
so that H+ conductance was carried out only by the remaining 50%. The calculated per-tetramer
conductance was therefore multiplied by 2, to account for the presumed half (by quantity)
activity of the protein. This final step yielded the proton flux per active tetramer, as reported
here.

Analysis
An equation describing electrodiffusive behavior in a channel at a fixed membrane
potential is:

JH

in

P[H ]out

(2)

where P is permeability of the channel for the ―fixed conditions.‖ An equation describing
saturating transporter activity is:

JH

J max
in

1

kd

.

(3)

[ H ]out

JH+in is the influx (net of ―fixed‖ efflux). The denominator in equation 3 represents the
probability of a multiply protonated histidine residue within the protein prepared to release a
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proton to the interior. The data, measured at various values of [H+]out, will be compared to these
two predictive functions. The null hypothesis, ―no saturation of transport rate,‖ will be rejected if
the

2

value for the best fit of equation 3 statistically excels compared to that for the best fit of

equation 2.

Figure 6.
Proton flux vs. pH.

Figure 6 shows the distinctive curves yielded when plotting H+ flux per M2 tetramer
against pH for either a proton channel (equation 2) or a transporter (equation 3).
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RESULTS
Proton Flux, Acid-Activation, and Amantadine Block Quantitation
Results of a range of liposome proton flux experiments performed October 2009 and
January-February 2010 at pHs ranging from 6.5 to 4.0 are plotted in Figure 7. Upon comparison
to Figure 6, the data more closely approximate a transport-characteristic, rather than channelcharacteristic, binding curve.

Figure 7.
Set 1 of activation-saturation experiments with M2(22-62) proteoliposomes (squares). Proton
flux measurements were done with pHo of 6.5 to 4.0, pHi =8.0. 0.1 mg M2(22-62):20 mg lipid:1
ml internal buffer liposome suspension was diluted 100-fold into pre-pHed, isoosmotic external
buffer containing citrate. For experiments with amantadine (circles), liposomes were incubated
in 0.1 mM amantadine overnight, and external buffer contained 0.1 mM amantadine as well.
Proton flux measurements were corrected for baseline H+ leakage into the liposomes prior to
valinomycin addition, and for valinomycin-induced H+ leak observed in protein-free liposomes.
Fluxes are doubled as a correction for protein orientation and gating. The saturation curve was
fitted with a pKa of 6.0, a maximum flux of 170 H+/second/tetramer from eq.3. The error bar for
each point represents ±1 S.E., calculated as the square root of the sum of the standard errors of
the means for the test group and the control (protein-free liposomes) group. From left to right,
N=6, 5, 6, 9, 8, and 4 for the protein; N=3, 3, 2, 3, 3, and 3 for the amantadine experiments.
Nominal membrane potential: -114 mV.
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Proton flux increased with decreasing pHo down to pH 5.5, but then dropped abruptly at
lower pHs. Amantadine blocked ~80% of proton flux at pH 5.5. At pH 6.5, the interexperimental
errors were too large to detect block in this set of experiments. Protein desensitization below pH
5.5 rendered detection of amantadine block difficult. Protein-free liposome fluxes were small (~1
H+/tetramer-s, calculated as if protein were present, data not shown) and were subtracted.
Transport rose following a theoretical binding curve having a pK of 6.0, and a maximum flux of
170 H+/tetramer-s.
A second set of experiments to validate the findings in Figure 7 was executed in JulyOctober, 2010, at some of the same pH points but also including data at intermediate pHs for
refinement of the acid activation and flux saturation patterns previously observed (Figure 8).

Figure 8.
Second set of activation-saturation experiments with M2(22-62) proteoliposomes (squares).
Proton flux measurements were done with pHo of 6.25 to 4.75, pHi = 8.0. 0.1 mg M2(22-62):20
mg lipid:1 ml internal buffer liposome suspension was diluted 100-fold into pre-pHed,
isoosmotic external buffer containing citrate. For experiments with amantadine (circles),
liposomes were incubated in 0.2 mM amantadine overnight, and external buffer contained 0.1
mM amantadine. Proton flux measurements were corrected for baseline H+ leakage into the
liposomes prior to valinomycin addition, and for valinomycin-induced H+ leak observed in
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protein-free liposomes. Fluxes are doubled as a correction for protein orientation and gating. The
saturation curve was fitted with a pKa of 6.5, a maximum flux of 30 H+/second/tetramer. The
error bar for each point represents ±1 S.E., calculated as the square root of the sum of the
standard errors of the means for the test group and the control (protein-free liposomes)
group. From left to right, N=9, 8, 8, 11, 8, 7, 8 for the protein; N=6, 5, 5, 5, 4, 5, 6 for the
amantadine experiments. Nominal membrane potential: -114 mV.

Results of the second set were similar to those in Figure 7. Proton flux increased with
decreasing pHo to 5.75, but then began to drop between pH 5.75 and 5.5. With amantadine
present, the flux was 100% blocked at pH 6.25. Amantadine block was reduced to near 0% at pH
5.5. Protein-free liposome fluxes ranged from 4 H+/tetramer-s at pH 5.75 to 17 at pH 4.75 and
were pre-subtracted from protein flux raw data. Transport rose following a theoretical binding
curve having a pK of 6.5, and a maximum flux of 30 H+/second/tetramer.
Measured peak proton flux rates through M2(22-62) in these liposome assays were 139
(Set 1) or 25 (Set 2) to protons per second per tetramer. The upper value exceeds any previously
published5,26,27, although a recent study using the full-length M2 protein and quantifying flux via
intravesicular Glu3 fluorescence reported rates of 45 protons/second/tetramer25.
A somewhat unexpected finding was the observation that the M2(22-62) truncate seemed
to lose function below pH 5.5-5.75, as evidenced by an abrupt drop in proton flux at low pHs and
reduction (or elimination) of amantadine block, often with higher flux into amantadine-bound
proteoliposomes than untreated ones. Figures 10 and 11 below show raw data following the pH
change through the time-course of a proton flux assay, first with robust proton uptake and
amantadine block at pH 6.5, then severely reduced uptake and block at pH 4.5. These traces,
though individual, were typical of experiments at those pHs.
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Figure 9.
Proton uptake per tetramer as a function of time, in the absence (black) and presence (gray) of
100 μM amantadine. pHex = 5.5, from experiment Set 1. The initial slopes (lines), after proteinfree liposome proton flux subtraction and pre-valinomycin drift subtraction, were 140 protons
per tetramer per second and 30 protons per tetramer per second, respectively, corresponding to
~80% blockage by amantadine23.
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Figure 10.
Raw data traces from the first set of activation-saturation liposome assays. Experiments were at
pH 6.5. Upper left corner legend identifies proteoliposomes only (maroon trace),
proteoliposomes incubated and assayed in 0.1 mM amantadine (pink trace), and protein-free
liposomes incubated and assayed in 0.1 mM amantadine (blue trace). Arrows indicate:
valinomycin injection (black), CCCP injection (green), two back-titrations of 30 nEq each of
HCl (purple). Red bars follow the approximate initial slope after valinomycin addition,
highlighting proton flux differences between amantadine-blocked and amantadine-free M2(2262), with all three cases showing baseline slow depolarization. Traces were vertically offset for
comparison purposes.
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Figure 11.
Raw data traces from the first set of activation-saturation liposome assays. Experiments were at
pH 4.5. Upper left corner legend identifies proteoliposomes only (maroon trace),
proteoliposomes incubated and assayed in 0.1 mM amantadine (pink trace), and protein-free
liposomes (blue trace). Arrows indicate: valinomycin injection (black), CCCP injection (green),
two back-titrations of 30 nEq each of HCl (purple). Red bars follow the approximate initial slope
after valinomycin addition, highlighting proton flux differences between amantadine-blocked
and amantadine-free M2(22-62), with all three cases showing baseline slow depolarization.
Traces were vertically offset for comparison purposes.
Factors to consider when interpreting Results
Limited, low-level alkali metal transport by M2 was suggested to be physiologically
valuable for virus acidification in the recent Leiding/Årsköld study25. Here, quantification of
slight K+ ―leak‖ through M2(22-62) was fully implemented, giving an improved estimate of
M2(22-62) selectivity and exploring the time course of vesicle depolarization by M2 transport of
K+. The small amount of citrate buffer (citric acid and sodium citrate) present in the external
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buffer solution was intended, initially, to reduce a steady upward pH drift observed in the first
experiments and believed to be due to CO2 diffusion into the rapidly stirring, originallyunbuffered solution. However, liposome depolarization time course experiments (Figure 12) and
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Figure 12.
A) pH traces with varying delays after acidification to evaluate total liposome proton-uptake
signal rundown, (the sum of the valinomycin and the CCCP uptake signals). Each trace is
representative of a set of three equivalent experiments. pH traces for protein-containing (black)
and protein-free (gray) liposomes were aligned vertically to start at different levels (at the
arbitrary reference time of t=2 min) for ease of comparison. The exact pHs at the time of
valinomycin addition were, from left to right: 6.147, 6.185, 6.173 (protein traces) and 6.160,
6,153, and 6.194 (protein-free traces). The start time is designated as the time of bath
acidification, which establishes a pH gradient but should only cause minimal H+ flux in the
absence of K+ transport. 0.1 mg M2(22-62):20 mg lipid:1 ml internal buffer diluted 100-fold into
citrate-free external buffer. Protein-free-liposome-subtracted specific activity at t=5 minutes:
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19±4 H+/tetramer-s (N=2; pHo 6.2). B) Logarithmic representation of total liposomal proton
uptake (representing total trapped volume). Diamonds (laterally offset for clarity) represent
proteoliposomes and squares represent protein-free liposomes. Total signal, corrected for
artifacts (measured separately) due to addition of ethanolic valinomycin and CCCP, was
normalized by extrapolation of the assumed exponential decay to 0-time total uptakes of 143±4
nEq H+ (proteoliposomes) and 200±40 nEq H+ (protein-free liposomes). Total heights were
corrected by subtraction of a small proportion, 15 nEq H+ (one half the back titration pH change)
in each case, to compensate for pH changes observed upon addition of the effectively alkaline
ethanolic reagents (valinomycin and CCCP), to liposome-free buffer. Error bars for each point
represent ±1 SD, N=320. 1

liposome-free pH-change tests (data not shown) indicated that the initial pH drift could only be
due to slight M2-induced K+ permeability of the liposomes. The rate of total signal decay was
used to indicate the rate of depolarization of liposomes deriving from K+ permeability. Because
trapped volume varied between liposome preparations, this required normalization of the total
signal heights extrapolated back to the time when the liposomes were first exposed to a pH
gradient (unlike the activation-saturation experiments, these assays’ higher-pH, citrate-free
external buffer required activating M2 by addition of HCl to bring pH down to a moreconductive level.) The total pH change/voltage signals from each experiment, corrected for
ethanolic ionophore injection artifacts, were first fitted with an exponential decay function and
then divided by the respective zero time (time of external buffer acidification) intercept for
trapped volume normalization before averaging with the other two experiments in its group. The
normalized averages were then fit with a unity-amplitude exponential decay function (solid lines
on the semi-log plot), the characteristic time of the protein-free liposome curve was subtracted
from the proteoliposome curve, and the result was multiplied by the zero-time intercept for the
protein-containing liposomes to obtain the denormalized decay due to K+ flux (nmol K+/minute)
through M2(22-62). This was then divided by the total protein content in the sample (0.15 nmol
1

Results obtained by colleagues under my supervision. See acknowledgements.
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tetramers) and converted to units of seconds. The difference between the protein-containing and
protein-free liposomes’ K+ leak/H+ uptake slopes was presumed to be due to different decays
during the 3 minute period between dilution and acidification, which apparently was greater for
the M2(22-62) liposomes than the protein-free liposomes, (also self-consistent with the steeper
slope for M2(22-62) liposomes). The normalization thus corrected for unequal initial effective
total trapped volumes at the time of acidification.
Inter-experimental variation in the shape of the valinomycin and CCCP peaks, the
baseline drift, and to a lesser extent in the shape of the back-titration pH drop were observed
during all liposome assays, both the activation-saturation type and the K+ depolarization assays
described above. The shape of the back-titration was used to identify variations in stirring.
Typically, the back-titration-induced pH/voltage change settled in about 2 seconds.
Initial flux was calculated from the linear portion of the valinomycin peak, within 2-7
seconds post-valinomycin injection. This approach was based on the assumption that the
valinomycin peak shape was a single exponential, but in some experiments there appeared to be
multiple exponentials, perhaps representing embedded compartments. Substantial baseline drift
before addition of valinomycin was also common, likely due to the inherent lipid permeability
to both protons and potassium ions.
In addition to variations in pH/voltage signal shapes, two major sources of uncertainty
might have affected specific proton (or even K+) flux estimates: liposome integrity and protein
functionality. Liposomes were assumed to have been largely impermeable to protons/ions,
enabling them to maintain a membrane potential. In protein quantification, any M2(22-62) not
forming parallel tetramers (monomers, dimers, surface-associated protein, protein dissolved in
water or lost in extrusion) would not have contributed to overall H+ flux, though calculations
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would have included it as being functional. There was also some decay in the polarization of the
vesicles after dilution and/or acidification and decay in the apparent initial flux during the dead
time. These uncertainties would all have led to underestimation of the specific H+ flux through
M2(22-62), so the values presented here represent lower bounds.
Finally, amantadine binding to lipid was considered only after activation-saturation
experiment Set 1 was completed. In those experiments, reported aqueous amantadine
concentrations may have been reduced by ~1.7%, after calculations based on the partition
constant of amantadine in charged phosophocholine bilayers being 8428, and E. coli lipid
possessing a similar amount of charge. For activation-saturation experiment Set 2, liposomes
were incubated in 0.2 mM amantadine and the external buffer bath was brought to 0.1 mM
amantadine before liposome addition.

DISCUSSION
Functional Characteristics of M2(22-62)
This research was designed to help resolve the question of whether M2 functions more as
a traditional proton channel, or instead conducts protons in an ion ―transporter‖ fashion. If the
protein were to act as a channel by opening in response to acidic pH and remaining open
(continuously or intermittently) as a proton floodgate, expected results would include:
1) No saturation of proton flux rate observed. Although channels with obligatory ion
binding sites can saturate, protons shuttled by Grotthus conductance via a water wire
would not.
2) Flux rate would increase as predicted by protein pore diameter and
concentration/electrical gradient alone.
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3) Little or no H+-selectivity.
If M2 behaved in the liposomes as a transporter, observations would yield:
1) Proton flux increasing as acid-activation point or pk (about pH 5.8) was reached.
2) Flux would keep increasing to a point, likely somewhere between pH 5.8 and 5.0,
then plateau to a level rather than continue to rise with [H+]. This would be the key
―saturation‖ point or maximum rate at which a transporter could move ions,
regardless of concentration/electrical driving forces. Proton conductance that was H+
selective.
This transporter-characteristic behavior was experimentally investigated and indicated by
data from the proteoliposome proton flux assays reported here. Measured proton flux rates
through M2 increased to pH values between 6.5 and 5.5, where the flux then ceased increasing.
The pK of transport, or the point at which proton flux is no longer access-limited but rather
translocation-limited, was determined with the saturation curves in Figures 7 & 8 to be 6.5-6.0.
One limitation of the results presented here, however, was the loss of most or all proton transport
function below pH 5.5. While full-length M2 in mouse erythroleukemia cells yielded proton
conductance data down to pH 41, this truncated version lost H+ transport capacity at low pH.
This fall of activity below pH 5.0-5.5 is consistent with the pH dependence of
tetramerization observed by Salom, et al, whose analytical ultracentrifugation studies using an
M2 transmembrane domain peptide (―M2 TMD,‖ residues 22-46) reported an increasing
prevalence of disassociated M2 TMD monomers relative to tri- or tetramers as pH decreased29.

31

Figure 13.
Relation of Set 1 activation-saturation data to per-channel flux rates observed in Xenopus oocyte
whole-cell voltage clamp assays. Dotted line represents a saturation curve with per-tetramer Jmax
of 279 protons, and a pK of activation of 6.0. As in Fig. 7, gray squares indicate proteoliposome
proton flux averages, and black circles indicate amantadine-incubated proteoliposome proton
flux averages. Measurements were corrected for baseline H+ leakage into the liposomes prior to
valinomycin addition, and for valinomycin-induced H+ leak observed in protein-free liposomes.

The Salom study also showed enhanced tetramerization of M2 monomeric subunits in the
presence of amantadine as pH dropped, relative to amantadine-free monomer suspensions. That
observation could help in understanding the pattern of amantadine block of proton transport
shown here: amantadine enhancement of flux with declining experimental pH. Block patterns
varied slightly from Set 1 to Set 2 of the liposome activation-saturation assays, and with proton
flux capacity so radically reduced by increasingly acidic pH, efficacy of amantadine in blocking
that flux was somewhat difficult to determine. It was clear, however, that amantadine did not
prevent conductance of H+ at low pH, and often served to increase proton flux above that in
untreated M2(22-62) liposomes.
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Figure 14.
Relation of Set 2 activation-saturation data to per-channel flux rates observed in Xenopus oocyte
whole-cell voltage clamp assays. Dotted line represents a saturation curve with per-tetramer Jmax
of 279 protons, and a pK of activation of 6.0. As in Fig. 8, gray squares indicate proteoliposome
proton flux averages, and black circles indicate amantadine-incubated proteoliposome proton
flux averages. Measurements were corrected for baseline H+ leakage into the liposomes prior to
valinomycin addition, and for valinomycin-induced H+ leak observed in protein-free liposomes.
Error bars are encompassed by the size of the markers.

M2(22-62) initial proton flux into buffer-saturated liposomes increased as external pH
dropped from 6.5-5.5, indicating acid activation of the protein.
Proton flux measurements at experimental pH of 5.5 and above were higher here than in
previous studies of M2 in liposomes due to a combination of factors. Some previous liposome
assays26,27 used a valinomycin-induced membrane potential to drive proton flux, but no pH
gradient from inside to outside the liposomes. Others5 included an extra-to-intra-liposomal pH
difference of about 1 unit, but did not have a voltage gradient. The data presented here were
gathered by utilizing at least 100-fold more [H+] outside the liposomes than in, and 100-fold
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higher [K+] inside than out. Twice the driving force on the protons yielded higher flux rates then
ever reported: up to 139 H+/tetramer/second, compared to a typical <10 H+/tetramer/second (at
most 45 H+/tetramer/second25) seen by others.
Additionally, the citrate buffer present in the extra-liposomal solution appeared to
contribute to the high flux rates. Initial assay design employed very weakly-buffered external
solution, but the extreme sensitivity of this solution composition to any addition of H+ ions
exacerbated the pre-valinomycin pH drift in the experiments, also making consistency and
reproducibility difficult for series of experiments at identical pHs. Including citrate buffer in the
external bath was a way to alleviate these difficulties, but was initially expected to also lower H +
initial flux rates through M2(22-62) by binding available H+. The observed increase in flux with
citrate-buffered external bath solution was unexpected, but upon further consideration it was
decided that the buffer must actually have functioned as a free H+ reservoir and delivery
apparatus, bringing protons to the ―depletion zone‖ created at the N-terminal side of the
transporter as the protein transfers H+ from outside the liposomes to inside8. Apparently, the
citrate buffer is what helped to quickly and effectively deliver protons to the N-terminus of the
channel/transporter, increasing the measured flux rates even further.
The observed loss of protein function at low pH could possibly be due, as mentioned
above, to monomerization of M2(22-62) tetramers. A possible explanation for this phenomenon
could be found in the same protonation of Histidine 37 that allows initiation of proton transport
activity through the protein. Protonating the third His of the tetramer is the event which initiates
H+ flux30, but forcing the external pH to low enough levels to add a fourth proton on the final
His residue might actually cause electrostatic repulsion of each monomer in the tetrad, shifting
M2(22-62) from a H+ transporting state to an H+-desensitized state. If this were true, then a data
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analysis model could present net proton transport activity as the product of the fraction of
tetramers that are in the triply-protonated, actively conducting state and the fraction of tetramers
that are over-protonated and desensitized, likely becoming monomerized. A chart was generated
in Microsoft Excel, using the Solver add-in to computer-fit the entire data set (Set 1 data and Set
2 data) and project this net transport curve.

Figure 15.
Black curve=flux saturation with a set pK of 6.01 and a computer-fit Jmax of 87.6 H+/sec/tetramer.
Red curve=protein loss of activity, with a set Jmax of 100 H+/sec/tetramer and a computergenerated pK of 4.7. Blue curve=net transport curve, the best fit to the data of a function of both
saturation and inactivation curves.

Linking both data sets to each other, such that the Jmax of saturation and pK of
inactivation of both were dependent on the saturation curve pKs being fixed at 6.0 (as justified
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by the MEL cell study1 and solid-state NMR-based mechanistic models23,30) and both Jmax of
inactivation being fixed at 100 H+/sec/tetramer. A net transport curve, dependent upon all data
gathered, was generated for each individual data set.

Figure 16.
Black curve=flux saturation with a set pK of 6.01 and a computer-fit Jmax of 87.6 H+/sec/tetramer.
Red curve=protein loss of activity, with a set Jmax of 100 H+/sec/tetramer and a computergenerated pK of 5.9. Blue curve=net transport curve, the best fit to the data of a function of both
saturation and inactivation curves.

This analysis indicated a saturation-inactivation pK of 4.7 in Set 1, but 5.9 in Set 2. Such
heightened sensitivity of the peptide to acidic pH after long-term storage strengthens the claim
that some form of peptide degradation, likely monomerization, occurred between the time when
data Set 1 was gathered and data Set 2 was gathered. Future assays with M2(22-62) will likely
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need to be completed within just a few months after peptide growth and purification, in order to
avoid compromising data-gathering efforts, especially if low-pH experiments are planned.
The relationship between protein structure and function is a crucial element of the current
efforts in the structural biology field to understand the M2 protein and generate new antiinfluenza drugs. The functional assays performed have most often been intracellular
electrophysiological assays, or now proteoliposome assays. But structural determination must be
carried out in often extreme conditions, such as radically low temperatures for X-ray
crystallography, stacked and compressed lipid bilayers for solid-state NMR spectroscopy, or
heavy detergent concentrations for solution-state NMR. Native-like tetramerization of the
protein is often difficult to achieve or determine, especially when using shorter constructs (M2
TMD, etc.) of the protein. The assumed structural changes M2 undergoes when transitioning
from non-conducting to conducting states in response to external pH have also required studies
to be carried out at an array of pHs, which can be logistically difficult. And, of course, the
particular site of amantadine binding in a functionally blocked M2 tetramer is of critical interest
to Influenza researchers.
The various structural approaches each have strengths and weaknesses, which has only
made the discourse more heated as different approaches yield very different results in the
attempts to elucidate M2 structure. Solution-state NMR of an M2(18-60) truncate with
rimantidine in short-chain lipid/detergent (dihexanoyl phosphatidylcholine) micelles showed a
nearly bilayer-perpendicular transmembrane helix, with rimantadine bound to the C-terminal,
amphipathic helix at Asp 44 rather than the demonstrated primary amantadine-resistance residue,
Ser 31. X-ray crystallography in octylglucoside of M2 TMD(25-45), however, showed
amantadine interacting with residues 27-34, in the heart of a 35 -tilted (with respect to the

37

tetramer axis) tetramer31. Still another method, solid-state NMR, showed the M2(22-62) protein
truncate in dioleoylphosphatidylcholine lipid bilayers having a transmembrane helix tilt angle of
32-22 (kinking at Gly 34), similar to the crystallographic finding, and the amphipathic helices
splayed out at 105 , facing D44 toward the tetramer axis, rather than the lipid headgroups23.
Arguments of the validity of lipid vs. detergent environments, temperature constraints, most
appropriate pH, etc. plague the structural biology discourse as researchers attempt to understand
M2.
Reports on proposed structures claim to indisputably explain the mechanism of H+ flux
through M2 (though a recent paper comparing structures determined at different pHs managed to
reconcile a few disparate explanations into a dynamic model of proton movement21). But until
functional assays can reliably validate their mechanistic models, it will be difficult to determine
which version to trust when searching for, for instance, for amantadine alternatives. Elucidation
of M2 H+ transport properties using an easily-quantified, well-controlled system like the
proteoliposome proton flux assay is an essential step toward distinguishing which structural
model(s) will be valuable in the search for new antiviral agents.
The functional data presented here significantly narrow the range of proposed structures
to those few which can support a proton transport, not channel, model of the M2 protein. This
implies a completely blocked pathway, interrupting any possible water wire. Definitive
determination of transporter function through these highly robust liposome assays will give
structural biologists an anchor from which to assess validity of proposed structural/mechanistic
models. In addition, the acid-activation response of M2 flux was characterized by these data in a
much more specific way than any previous studies, distinctly demonstrating an increase in H +
transport function from pH 6.5-5.5, and identifying the optimal transport pH in the narrow range
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of 5.5-5.75. The observed amantadine effects on H+ flux, evident in Set 2: loss of block
capability as proton flux rates rose, then apparent stabilization of a blocked tetrameric form of
M2(22-62)—possibly allowing proton flux around the drug in its binding site—will also be
crucial in unequivocally identifying the exact mechanism of amantadine binding--the key to
development of new anti-influenza pharmaceuticals.

APPENDIX
Optimal Liposome Protein Density Determination
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Figure 17.
To assess the oligomerization of M2(22-62), the proton transport rate as a function of protein
density was measured. This figure shows the log of the initial liposomal proton uptake rate after
valinomycin injection (H+/s) plotted against log of peptide content (nmoles of tetramer in the 3ml assay). The theoretical line of unity slope shows the best fit of a line constrained to pass
through the origin on a linear-linear plot, with slope of 23.8 H+/tetramer-s after protein
orientation correction.
Optimal protein concentration was determined to be 0.1 mg protein:20 mg lipid by
assaying proton flux into liposomes comprised of 0.05-0.2 mg protein:20 mg lipid and
observing the highest flux rates at the 1:200 ratio.
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Liposomal Lipid Quantitation/Verification
Quantification of liposomal lipid amount was necessary for determination of trapped
volume, and to evaluate efficiency of the different extruders. A phosphate determination assay,
based on that developed by Chen, Toribara, and Warner24, was used to evaluate phospholipid
amounts in purified lipid aliquots, unextruded lipid-protein suspensions, and suspensions passed
through Avestin and Avanti extruders. Rather than using the typical internal liposome buffer,
which contains phosphate and would confound the assay, liposomes were suspended in a buffer
of 100 mM KCl, 10 mM HEPES buffer, pH 8.0. An array of PO4 standards was assayed
concurrently in order to generate a standard curve for phosphate quantity in the lipid or liposome
samples. Briefly, the assay protocol consisted of: the lipid phase was extracted from the aqueous
phase using methanol and chloroform. Organic solvents were evaporated with nitrogen gas, and
10% Mg(NO3)2•6 H2O in ethanol was added. Mixture was evaporated/ashed over a flame until
white. 1N HCl was added, solution vortexed, and then hydrolyzed in boiling water for 15
minutes. A solution of 1 part 10% ascorbic acid:6 parts molybdenum solution (1 part 6N
H2SO4:2 parts H2O:1 part 2.5% ammonium molybdate) was added and allowed to incubate for
20 minutes. Phospholipid concentration was proportional to OD at 820 nm. Unextruded
liposome samples averaged 0.125 absorbance units, Avanti extruder samples averaged 0.120
absorbance units, and Avestin extruder samples averaged 0.145 absorbance units—obviously no
lipid was lost from that extruder! These data indicated that little, if any, lipid was lost in
extrusion with any of the equipment used.
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Liposomal Protein Quantitation Attempts
Proteoliposome protein quantitation assays were not successful. Methods attempted
included the BCA assay, purchased in a kit by Pierce from Thermo-Fisher Scientific, which
utilized bicinchoninic acid to colorimetrically indicate protein quantity via UV absorbance at 562
nm. Protein control liposomes with bovine serum albumin were created, but were imperfect as
reference proteoliposomes because of the inherent differences in liposome formation around a
water-soluble protein versus a membrane protein. But the difficulty of isolating protein from
lipid when assaying liposomes proved to be the confounding factor. Lipid interference was such
that proteoliposomes and protein-free liposomes showed similar absorbance at 562 nm.
An acetone precipitation method was attempted, based on a ―Tech Tip‖ included in the
BCA assay documentation, to eliminate the contaminant lipid. The steps were: add 4x volume of
cold acetone to protein standards and blanks, vortex and incubate 30 min at -20ºC, centrifuge 10
minutes in a microcentrifuge at maximum speed, pour off supernatants and allow acetone to
evaporate for 30 minutes at room temperature, then run BCA assay as above. M2(22-62) stock
samples, suspended in methanol to a known protein concentration, were used as standards as
well as BSA suspended in HEPES buffer. Methanol-suspended stock M2(22-62) was also diluted
1 part:2 parts water and spectroscopically analyzed for protein concentration before acetone
precipitation, to be utilized as another standard. Unextruded, Avanti-extruded, Avestin-extruded,
and protein-free liposomes were all assayed.

A nitric acid-based assay, based on the nitration of tyrosine residues in peptides, with
resulting absorbance at 358 nm, was also attempted32. This assay was difficult and dangerous to
perform, and the cuvettes used were melted and warped by the acid.
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The Bradford assay using Coomassie Blue dye (or in this case, Sigma Brilliant Blue G250—NOT ―R‖!), ethanol, and phosphoric acid as the colorimetric assay solution was the final
attempt at protein quantitation in the liposomes. This assay allowed for low concentrations of
certain detergents33, including n-octylglucoside, which enabled detergent-solublization of the
liposomes to eliminate lipid contamination. 30% O.G. solution was used, then added to
liposomes to a total concentration of 10% O.G. before reagent addition. Absorbance at 595 nm
was to indicate total protein concentration, but results were confounding, as with the other assays
attempted. It was at this point that the Leiding, et al25 study was published, using a modification
of a detergent-compatible commercial assay kit and demonstrating nearly 100% protein retention
after liposome extrusion. In future studies, this method will be the assay of choice for liposome
protein quantitation.
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